IR-Med Inc., a development stage medical device company, focuses on the development of non-invasive devices for various medical indications. It is developing PressureSafe, a handheld optical monitoring device to support early detection of pressure injuries to the skin and underlying tissue primarily caused by prolonged pressure associated with bed confinement; and Nobiotics, an otoscope to support physicians with an immediate indication as to whether mid-ear, a common malady in children. The company is headquartered in Rosh Pina, Israel.
Stock data | 2024 | Change |
---|---|---|
Price | $0.82999998 | N/A |
Market Cap | $58.04M | N/A |
Shares Outstanding | 69.92M | N/A |
Employees | 7.00 | N/A |